Ann R Coll Surg Engl 2010; 92: [225][226][227][228][229][230] 225 Despite significant advances in cancer treatment over the past decade, colorectal cancer (CRC) remains a major source of cancer-related mortality, being the second commonest malignancy in the UK and accounting for 10% of all cancer-related deaths.1 The majority of these deaths result from the development of metastatic disease. Approximately one-third of patients with CRC present with synchronous liver or lung metastases, with a further 8-25% developing metachronous disease following primary tumour resection.2,3 Changes in surgical and radiological techniques, in addition to new chemotherapeutic regimens, now enable patients with advanced disease, whose only option in the past would have been palliation, to be considered for potentially curative treatment.
4The so-called 'postcode' provision of healthcare services and treatments in the UK has been investigated and highlighted across a range of medical specialities.5-10 However, the majority of these studies have been conducted on a national level, subdividing populations into either strategic health authorities, primary care trusts or medical specialty. 5,6,10 Few investigators have examined the potential inequality of provision at a truly local level within one region. Inequalities in access to healthcare services have previously caused conflict between patients and healthcare HEPATOBILIARY SURGERY Ann R Coll Surg Engl 2010; 92: 225-230